糖心vlog

[Skip to Navigation]
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue
糖心vlog Home
JAMA Ophthalmology
Sign In

New Online

Current Issue Past Issues

Year

Day

2024
November October
October 31, 2024
Original Investigation

Economic Burden of Late-Stage Age-Related Macular Degeneration in Bulgaria, Germany, and the US

Nabin Paudel, PhD; Laura Brady, PhD; Petia Stratieva, MD, PhD; et al.
Abstract Full Text
open access
JAMA Ophthalmol. Published online October 31, 2024. doi:10.1001/jamaophthalmol.2024.4401

This economic evaluation study estimates the economic burden of late-stage age-related macular degeneration in 3 countries.

Validation of the Online Collaborative Ocular Tuberculosis Study Calculator for Tubercular Uveitis

Ludi Zhang, MBBS; William Rojas-Carabali, MD; Shannon Sheriel Choo, BS; et al.
Abstract Full Text
JAMA Ophthalmol. Published online October 31, 2024. doi:10.1001/jamaophthalmol.2024.4567

This diagnostic study investigates the predictive accuracy of the Collaborative Ocular Tuberculosis Study (COTS) calculator score 4 and 5 in guiding initiation of antitubercular therapy in patients with clinically suspicious tubercular uveitis.

Invited Commentary

Holistic Evaluation of the Burden of Eye Disease

David W. Hutton, PhD; Joshua D. Stein, MD, MS
Abstract Full Text
JAMA Ophthalmol. Published online October 31, 2024. doi:10.1001/jamaophthalmol.2024.4801

Tuberculosis Uveitis鈥擟onsumed by Uncertainty

Nicholas A. V. Beare, MB ChB, MD; Geraint Davies, BM, PhD
Abstract Full Text
JAMA Ophthalmol. Published online October 31, 2024. doi:10.1001/jamaophthalmol.2024.4815
JAMA Ophthalmology Clinical Challenge

Branch Retinal Artery Occlusion in an Adolescent Male

Darren A. Chen, MD; Jennifer C. W. Hu, MD; K. Matthew McKay, MD
Abstract Full Text
has active quiz
JAMA Ophthalmol. Published online October 31, 2024. doi:10.1001/jamaophthalmol.2024.4539

A 17-year-old male with an unremarkable medical history presented with 2 days of painless blurred vision in the right eye. Three weeks prior, he was admitted with fever, myalgias, hepatosplenomegaly, lymphadenopathy, and truncal rash. What would you do next?

Research Letter

AI in Ophthalmology

Use of Artificial Intelligence鈥揃ased Detection of Diabetic Retinopathy in the US

Shreya A. Shah, BS; Jared T. Sokol, MD, MBA; Karen M. Wai, MD; et al.
Abstract Full Text
free access
JAMA Ophthalmol. Published online October 31, 2024. doi:10.1001/jamaophthalmol.2024.4493

This cohort study examines patient data from January 2019 to December 2023 to evaluate national trends in the use of artificial intelligence鈥揵ased screenings to detect diabetic retinopathy among patients with types 1 or 2 diabetes.

Comment & Response

Considerations Regarding Association of Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy

Jay B. Lusk, MD, MBA; Brian Mac Grory, MB BCh BAO, MHSc; Fan Li, PhD
Abstract Full Text
JAMA Ophthalmol. Published online October 31, 2024. doi:10.1001/jamaophthalmol.2024.4515

Considerations Regarding Association of Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy

Jim Shenchu Xie, MD; Jonathan Trobe, MD; Edward Margolin, MD
Abstract Full Text
JAMA Ophthalmol. Published online October 31, 2024. doi:10.1001/jamaophthalmol.2024.4518

Considerations Regarding Association of Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy

Sylvie Feldman-Billard, MD
Abstract Full Text
JAMA Ophthalmol. Published online October 31, 2024. doi:10.1001/jamaophthalmol.2024.4521

Considerations Regarding Association of Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy

Dong Wook Kim, MD; Caroline M. Apovian, MD
Abstract Full Text
JAMA Ophthalmol. Published online October 31, 2024. doi:10.1001/jamaophthalmol.2024.4524

Considerations Regarding Association of Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy

Judith C. Maro, PhD; Richard Platt, MD, MSc; Sengwee Toh, ScD
Abstract Full Text
JAMA Ophthalmol. Published online October 31, 2024. doi:10.1001/jamaophthalmol.2024.4527

Considerations Regarding Association of Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy

Mahyar Etminan, PharmD, MSc; Mohammad A. Mansournia, MD, PhD
Abstract Full Text
JAMA Ophthalmol. Published online October 31, 2024. doi:10.1001/jamaophthalmol.2024.4530

Considerations Regarding Association of Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy

Qi N. Cui, MD, PhD
Abstract Full Text
JAMA Ophthalmol. Published online October 31, 2024. doi:10.1001/jamaophthalmol.2024.4533

Considerations Regarding Association of Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy鈥擱eply

Joseph F. Rizzo III, MD; Jimena Tatiana Hathaway, MD, MPH; Madhura P. Shah, MD
Abstract Full Text
JAMA Ophthalmol. Published online October 31, 2024. doi:10.1001/jamaophthalmol.2024.4536
October 24, 2024
Original Investigation

Cataracts Associated With Fibroblast Growth Factor Receptor Inhibitors for Cholangiocarcinoma

Isabell Kassaye, BA; Adam Alyafaie, BS; Karen Zhang, BA; et al.
Abstract Full Text
JAMA Ophthalmol. Published online October 24, 2024. doi:10.1001/jamaophthalmol.2024.4395

This case study describes cases of cataract formation or progression in patients with intrahepatic cholangiocarcinoma treated with fibroblast growth factor receptor inhibitor (FGFRi) and characterizes the ophthalmologic features, risk factors, and outcomes for FGFRi-associated cataracts.

Curcuma-Based Nutritional Supplements and Risk of Age-Related Macular Degeneration

Amer F. Alsoudi, MD; Karen M. Wai, MD; Euna Koo, MD; et al.
Abstract Full Text
has audio
JAMA Ophthalmol. Published online October 24, 2024. doi:10.1001/jamaophthalmol.2024.4400

This cohort study investigates the outcomes of patients with and without age-related macular degeneration (AMD) who were taking curcuma-based nutritional supplements.

  • Podcast: Curcumin-Based Nutritional Supplements and Risk of AMD
Invited Commentary

Separating Supplement Effects From the Patients Who Use Them

Brian L. VanderBeek, MD, MPH, MSCE
Abstract Full Text
JAMA Ophthalmol. Published online October 24, 2024. doi:10.1001/jamaophthalmol.2024.4569
Correction

Error in Rounding

Abstract Full Text
free access
JAMA Ophthalmol. Published online October 24, 2024. doi:10.1001/jamaophthalmol.2024.4722
October 21, 2024
Invited Commentary

Three vs 6 Cycles of Adjuvant Chemotherapy for Retinoblastoma

Ann M. Leahey, MD; Amish Shah, MD, PhD; Carol L. Shields, MD
Abstract Full Text
JAMA Ophthalmol. Published online October 21, 2024. doi:10.1001/jamaophthalmol.2024.4859
October 17, 2024
Original Investigation

Tissue Plasminogen Activator or Perfluoropropane for Submacular Hemorrhage in Age-Related Macular Degeneration: A Factorial Randomized Clinical Trial

George S. P. Murphy, MB, BCh, BAO; Azahir Saleh, MBBS; Salma Ayis, PhD; et al.
Abstract Full Text
JAMA Ophthalmol. Published online October 17, 2024. doi:10.1001/jamaophthalmol.2024.4297

This randomized clinical trial investigates if tissue plasminogen activator (TPA) or perfluoropropane improve visual acuity or resolution of submacular hemorrhage secondary to neovascular age-related macular degeneration (AMD) in eyes treated with ranibizumab.

Invited Commentary

Can We Do Better for Submacular Hemorrhage in Neovascular AMD?

Christina Y. Weng, MD, MBA
Abstract Full Text
JAMA Ophthalmol. Published online October 17, 2024. doi:10.1001/jamaophthalmol.2024.4378

Latest Issue

Untreated Vision Loss as a Modifiable Dementia Risk Factor
Viewpoint | November 1, 2024
Diabetic Retinopathy in Youths鈥擜 Potentially Unappreciated Public Health Catastrophe
Viewpoint | November 1, 2024
Incidence and Risk of Depressive Disorder in Patients With Retinitis Pigmentosa
Original Investigation | November 1, 2024
View More
×
Access your subscriptions
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Get full journal access for 1 year
Get unlimited access and a printable PDF ($40.00)鈥�
Sign in or create a free account
Access your subscriptions
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Get full journal access for 1 year
Get unlimited access and a printable PDF ($40.00)鈥�
Sign in or create a free account
Sign in to access free PDF
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Save your search
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Make a comment
Free access to newly published articles
To register for email alerts, access free PDF, and more
Create a personal account or sign in to:
  • Register for email alerts with links to free full-text articles
  • Access PDFs of free articles
  • Manage your interests
  • Save searches and receive search alerts
Privacy Policy